Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study
Hesham Tarraf(Cairo University), Naser Behbehani(Mubarak Al Kabeer Hospital), François Montestruc(Hospital de Clínicas), Anamarija Gjurovic(AstraZeneca (France)), Hamdan Al‐Jahdali(King Saud University), H. Haouichat(Hôpital Nord), Roozbeh Naghshin(Rasool Akram Hospital), Bassam Mahboub(University of Sharjah), Abdul Hameed Al Qaseer(Iraqi University), Basheer Khassawneh(Jordan University of Science and Technology)
Cited by 68
Related Papers
Role of Transforming Growth Factor–β in Airway Remodeling in Asthma
|American Journal of Respiratory Cell and Molecular Biology|2010|420
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
|New England Journal of Medicine|2018|392
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
|The Lancet Respiratory Medicine|2021|297
Histopathology of Middle East respiratory syndrome coronovirus (<scp>MERS</scp>‐CoV) infection – clinicopathological and ultrastructural study
|Histopathology|2017|290
Improper inhaler technique is associated with poor asthma control and frequent emergency department visits
|Allergy Asthma and Clinical Immunology|2013|283